Skip to playerSkip to main content
  • 6 hours ago
New research reveals mitochondrial DNA copy number links to cancer severity and therapy response. The study found that higher mtDNA levels correlate with genetic mutations in cancer cells and influence gene expression tied to tumor growth and chemotherapy. Researchers at the Indian Institute of Technology Kharagpur suggest these findings may lead to new cancer management strategies. This work highlights the compensatory role of mitochondria in cancer cells and opens avenues for further investigation into mitochondrial functions in cancer progression. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

🗞
News
Transcript
00:00Mitochondrial DNA levels in cancer cells link closely to tumor growth in chemotherapy response.
00:06Researchers publishing in the EFEBS journal analyzed multiple cancers
00:10and found mtDNA copy number correlates with genetic mutations inside tumors.
00:16Higher mtDNA levels appear to compensate for damaged mitochondrial function in cancer cells.
00:21This change also matches shifts in gene activity tied to how cancer responds to chemotherapy.
00:27Notably, high mtDNA copy numbers connect with genes that promote tumor survival and growth.
00:33Ritaman Dhar, a lead researcher at the Indian Institute of Technology, Kharagpur, said,
00:38Our results reveal a close association of mtDNA copy number with cancer progression and therapy response.
00:46These findings could open new paths for cancer treatment by targeting mitochondria.
00:50Understanding mtDNA's role might reshape how doctors manage cancer in the future.
00:55Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools.

Recommended